We pondered the set-up of the molecular section within the Microbiology department during the process of deciding on which instruments to purchase. As with the implementation of any new assay, we had to look at specific facility requirements, personnel requirements, and workflow issues. However, more details than usual were involved with the creation of this new molecular atmosphere; bringing in molecular assays was not as simple as other implementations had been. I was completely out of my comfort zone and had no idea where to begin. As I started the site visits, I began to understand the complexity of building a molecular atmosphere; these visits gave me a first-hand look at what I needed to create. It was scary and exciting-it became evident that I would need lots of time for this project.
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While visiting the various facilities, I took detailed notes and asked lots of questions encompassing the general topic of how to create a molecular atmosphere and specific topics related to the assays themselves. The technologists appreciated my questions, understanding that this type of testing was new to many, and were extremely helpful in offering their knowledge in the field.
I returned with the information I had learned and started thinking about the guidelines that we would need to implement at OSF Saint Francis Medical Center. Our system laboratory was certified by the College of American Pathologists (CAP) and we followed guidelines proposed by the Clinical Laboratory Standards Institute (CLSI). At the time, these regulatory agencies had proposed certain guidelines for molecular diagnostic testing; however, the guidelines were not always stated clearly, making it difficult to implement their standards. I had to rely on the information I had received during my site visits (as well as information provided by the CAP and CLSI) to create the guidelines for our molecular section.
As mentioned in the previous installment of this series, the methodology our molecular section focuses on is real-time polymerase chain reaction (RT-PCR). One of the major concerns with any type of PCR testing is the risk of contamination. Where the contamination occurs, however, depends on the type of PCR being performed. During my research I learned that with conventional PCR, contamination is common with amplified product because the technologist is working with an open system. However, with real-time PCR, the risk of contamination decreases because amplification of the product occurs in a closed system. This does not mean that RT-PCR carries no risk of contamination. There is still the possibility of contamination at the point of processing the original specimen and the control materials. Although we were to be performing RT-PCR, which is less conventional, I chose to be more conservative in how we built the molecular atmosphere and its workflows, to decrease the possibility of contamination.
Contamination prevention begins with separation of work areas. We contemplated the different processes and workspaces that would be necessary for RT-PCR workflow. We decided to create 3 designated areas: the reagent preparation area (clean) to prepare PCR reagents only; a sample processing area (dirty), which included nucleic acid extraction and sample loading; and an amplification area (semiclean), where the thermocycler would perform amplification and detection of target analytes. In addition to creating these areas, the CLSI recommends that a unidirectional workflow be implemented when performing molecular procedures, to eliminate any back-and-forth actions that might occur throughout the testing process. This prevents contamination and keeps the process streamlined. A clean area is free of any target DNA or RNA (patient sample or manufactured controls). A dirty area is where the patient sample or control would be manipulated. The semiclean area is where the thermocycler is located. At this point in the process, the extracted patient sample and/or control and reagents are contained in a closed vessel. There isn't any direct manipulation of sample or reagent here since they are being amplified and detected within the instrument. The vessel in which they are contained is closed the entire time. However, there is always room for contamination if a vessel should break for some reason.
We needed not only separate work areas but also to designate materials and working reagents for each of the specified areas. We didn't want to share anything between areas because doing so could be a source of contamination. This meant that we had to provide dedicated laboratory coats, gloves, aerosol-resistant pipette tips with designated pipettes, centrifuges, vortexes, heat blocks, reagent water, and any other working material required for each designated area. The required contents for each specified areas are described in Figure 1 .
Each area should be cleaned daily, before and after each use. We also clean in between performing various assays.
We chose cleaning reagents and methods based on manufacturer's recommendations, consultation with other laboratories, and CLSI and CAP guidelines. To successfully decontaminate each area, one must clean all surfaces with a 10%-bleach solution (made daily), followed by a 70%-ethanol solution. All pipettes and instrumentation are cleaned with a reagent called DNA Away (Thermo Fischer Scientific Inc, Waltham, MA), an alkali hydroxide solution used to degrade DNA and RNA that may be present on surfaces. A final rinse with clinical laboratory reagent water should be performed.
Changing gloves and lab coats is also an important part of preventing contamination when performing RT-PCR. We implemented this step when moving from one designated area to another and between specific tasks within each of those areas. We also made a habit of changing gloves between working with positive and negative control substances.
During this process we didn't incorporate a method to check for contamination; we assumed that we could see any evidence of contamination during our daily runs. After our first inspection by the CAP, I learned that it was necessary to perform contamination checks (ie, swipe tests) on a routine basis. This not only helps prevent contamination issues before they start but also helps when troubleshooting possible contamination incidents. Hence, we now perform a swipe test on a quarterly basis by swiping each of the designated areas with swabs and analyzing the swab surface to rule out any possible contamination. Our workflows At this point, we had made plans for the general design of the molecular section and had begun to order the required materials. We began the planning stages for the validation process for herpes simplex virus typing via RT-PCR, the first assay we wanted to implement. Before validation could be performed, however, we needed to develop the protocol for the assay in-house. We also needed to complete training and assessment of the technologists. We were well into the process but still at the beginning of our adventure.
In the third installment of this series, I will describe the details of creating a protocol for a laboratory developed assay (specifically HSV and Bordetella). I will also explain the validation process for these non-FDA approved assays. LM
